Targeted Therapy Associated With Lower SPM Risk Among Treated Patients With CLL
February 6th 2024Investigators found patients receiving chemotherapy had a greater risk of a secondary primary malignancy (SPM) compared with those treated with targeted therapies or those whose chronic lymphocytic leukemia (CLL) was left untreated.
Read More
Medicare Value-Based Purchasing Program Yields Comparable 30-Day Mortality Rates Across Hospitals
February 5th 2024Although 30-day mortality rates did not worsen for Medicare beneficiaries at hospitals with high proportions of Black patients compared with other hospitals, gaps in outcomes widened for Black adults with pneumonia under the Medicare Value-Based Purchasing Program.
Read More
Pre-, Postinfusion Protocol Recommendations for Delandistrogene Moxeparvovec Use in DMD
February 5th 2024The gene therapy delandistrogene moxeparvovec-rokl, also known as Elevidys (Sarepta Therapeutics) is indicated to treat Duchenne muscular dystrophy (DMD) in ambulatory patients aged 4 to 5 years, and Sarepta recently filed supplemental data with the FDA seeking to expand the labeled indication.
Read More
Permanent Pacemaker Implantation Frequently Follows Tricuspid Valve Surgery, Study Finds
February 5th 2024Among Medicare beneficiaries, implantation was especially frequent for female patients and those undergoing tricuspid valve replacement with or without concomitant left-sided heart surgeries.
Read More
COVID-19 Vaccination Rates Far Lower in Patients With SCD Compared With General Population
February 4th 2024A state-wide analysis draws attention to the fact individuals with sickle cell disease (SCD) completed a vaccination against COVID-19 at nearly half the rate of individuals without SCD.
Read More
Health Equity and Access Weekly Roundup: February 3, 2024
February 3rd 2024The Center on Health Equity and Access provides real-time updates, shares cutting-edge research, and supports continuous efforts dedicated to tackling health care disparities and enhancing widespread access to high-quality health services.
Read More
Contributor: Navigating Health Equity in 2024: The Evolution of Accountability, Part 2
February 2nd 2024The article emphasizes the significance of accreditations in addressing health disparities and promoting health equity, highlighting programs for achieving accreditation and advocating for the integration of social determinants of health (SDOH) and health equity practices within pharmacy and health care.
Read More
CD137+ Tumor Infiltrating Lymphocytes Correlate With OS in Ovarian Cancer, Study Finds
February 2nd 2024In patients with high-grade ovarian cancer, an increased proportion of CD3+ CD137+ tumor infiltrating lymphocytes (TILs) correlated with favorable overall survival outcomes. However, proportions of CD3+ or CD3+ CD8+ TILs did not show significant associations with OS.
Read More
Uncertainty, Coping Strategies Common Among Patients With AML, High-Risk MDS
February 2nd 2024Patients with comorbid acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) expressed a desire to discuss treatment options and maintain normalcy; they were not willing to have conversations involving their prognosis and future.
Read More
Hospitalization, ER, and Medication Discontinuation Rates Still High in PNH
February 2nd 2024A retrospective analysis surveys the treatment landscape and patterns of patients with paroxysmal nocturnal hemoglobinuria (PNH), illuminating high hospitalization rates and emergency department use despite the availability of multiple treatment options.
Read More
Evidence Linking Sleep to Improved Lower Back Pain Outcomes Is Weak, More Studies Needed
February 2nd 2024A systematic review of randomized controlled trials and prospective cohort studies concludes that sleep could be a prognostic component of lower back pain, but better evidence is needed.
Read More
Pandemic-era policies that made it easier for patients to receive opioid addiction treatment will continue permanently; the Biden administration is facing pressure from Democrats and reproductive health groups to make sure the first OTC birth control pill is affordable; a FDA expert panel on Friday is set to resume the debate over how to make pulse oximeters more accurate for people with darker skin.
Read More
Depression in Heart Failure: Data Support Psychotherapy or Medication Intervention
February 1st 2024The findings not only underscore the efficacy of 2 major interventions—Behavioral Activation Psychotherapy (BA) and Antidepressant Medication Management (MEDS)—but also support patient autonomy in choosing their preferred path to mental well-being.
Read More
Bevey Miner: Unpacking the 21st Century Cures Act, the Role of Open Comment Periods
February 1st 2024Bevey Miner, executive vice president of health care strategy and policy, Consensus Cloud Solutions, discusses the complex landscape of proposed health care rules, and the potential impact of CMS' Advancing Interoperability and Prior Authorizations Rule.
Read More
Further Studies Required as MS DMT Exposure During Pregnancy Increases
February 1st 2024A large-scale, population-based study examined patterns of disease-modifying therapy (DMT) exposure in pregnant patients with MS since 2010, revealing increased occurrences and the need for future studies to examine the impact of newer-developed DMTs.
Read More
Telehealth, e-Health Psychological Interventions Potentially Promote Sexual Health in CRC
February 1st 2024Patients with colorectal cancer (CRC) could participate in telehealth and e-health interventions to promote their sexual health, although efficacy of these interventions needs to be further studied.
Read More